Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $276B |
| FY2017, ended Dec 31, 2017 | $152B |
| FY2018, ended Dec 31, 2018 | $65.9B |
| FY2019, ended Dec 31, 2019 | $97.5B |
| FY2020, ended Dec 31, 2020 | $94.7B |
| FY2021, ended Dec 31, 2021 | $104B |
| FY2022, ended Dec 31, 2022 | $91.3B |
| FY2023, ended Dec 31, 2023 | $139B |
| FY2024, ended Dec 31, 2024 | $179B |
| FY2025, ended Dec 31, 2025 | $323B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $323B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $119B |
| FY2017, ended Dec 31, 2017 | $113B |
| FY2018, ended Dec 31, 2018 | $114B |
| FY2019, ended Dec 31, 2019 | $90.2B |
| FY2020, ended Dec 31, 2020 | $75.8B |
| FY2021, ended Dec 31, 2021 | $56.5B |
| FY2022, ended Dec 31, 2022 | $29.1B |
| FY2023, ended Dec 31, 2023 | $35.3B |
| FY2024, ended Dec 31, 2024 | $38.7B |
| FY2025, ended Dec 31, 2025 | $45.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $52.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.50B | −$6.04B |
| FY2017, ended Dec 31, 2017 | −$8.48B | −$88.0M |
| FY2018, ended Dec 31, 2018 | −$22.4B | −$1.65B |
| FY2019, ended Dec 31, 2019 | −$4.98B | $6.52B |
| FY2020, ended Dec 31, 2020 | $5.70B | $1.99B |
| FY2021, ended Dec 31, 2021 | −$6.34B | $2.23B |
| FY2022, ended Dec 31, 2022 | $336M | $4.55B |
| FY2023, ended Dec 31, 2023 | $9.48B | $4.33B |
| FY2024, ended Dec 31, 2024 | $6.56B | $3.68B |
| FY2025, ended Dec 31, 2025 | $8.70B | $7.26B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.10B | $8.02B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $48.1B |
| FY2017, ended Dec 31, 2017 | $43.3B |
| FY2018, ended Dec 31, 2018 | $31.1B |
| FY2019, ended Dec 31, 2019 | $35.8B |
| FY2020, ended Dec 31, 2020 | $36.5B |
| FY2021, ended Dec 31, 2021 | $15.8B |
| FY2022, ended Dec 31, 2022 | $15.8B |
| FY2023, ended Dec 31, 2023 | $15.2B |
| FY2024, ended Dec 31, 2024 | $13.6B |
| FY2025, ended Dec 31, 2025 | $12.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.76B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $136B |
| FY2017, ended Dec 31, 2017 | $133B |
| FY2018, ended Dec 31, 2018 | $102B |
| FY2019, ended Dec 31, 2019 | $90.9B |
| FY2020, ended Dec 31, 2020 | $74.9B |
| FY2021, ended Dec 31, 2021 | $35.2B |
| FY2022, ended Dec 31, 2022 | $24.1B |
| FY2023, ended Dec 31, 2023 | $20.9B |
| FY2024, ended Dec 31, 2024 | $19.3B |
| FY2025, ended Dec 31, 2025 | $20.5B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $19.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 5.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.09B |
| FY2017, ended Dec 31, 2017 | 1.09B |
| FY2018, ended Dec 31, 2018 | 1.09B |
| FY2019, ended Dec 31, 2019 | 1.09B |
| FY2020, ended Dec 31, 2020 | 1.10B |
| FY2021, ended Dec 31, 2021 | 1.10B |
| FY2022, ended Dec 31, 2022 | 1.09B |
| FY2023, ended Dec 31, 2023 | 1.09B |
| FY2024, ended Dec 31, 2024 | 1.07B |
| FY2025, ended Dec 31, 2025 | 1.05B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.03B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$22.6B | — |
| FY2017, ended Dec 31, 2017 | — | — |
| FY2018, ended Dec 31, 2018 | — | $336M |
| FY2019, ended Dec 31, 2019 | — | $400M |
| FY2020, ended Dec 31, 2020 | — | $353M |
| FY2021, ended Dec 31, 2021 | $107M | $305M |
| FY2022, ended Dec 31, 2022 | $1.05B | $143M |
| FY2023, ended Dec 31, 2023 | $1.23B | $192M |
| FY2024, ended Dec 31, 2024 | $5.83B | $286M |
| FY2025, ended Dec 31, 2025 | $7.55B | $325M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.50B | — |
Valuation
At current price- Market Cap
- $308B
- P/E
- 33.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.9×
- Price / Book
- 17.6×
- EV / EBITDA
- 31.1×
Growth
Trailing 12 months- Revenue (TTM)
- $52.6B
- Revenue Growth YoY
- 19.6%
- Revenue CAGR 3Y
- 16.3%
- Revenue CAGR 5Y
- −9.6%
- EPS Growth YoY
- 15.5%
- Net Income Growth YoY
- 12.9%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 17.7%
- Net Margin
- 17.3%
- FCF Margin
- 15.3%
- Return on Equity
- 50.1%
Earnings
Trailing 12 months- Net Income
- $9.10B
- EPS (diluted)
- $8.66
- EBITDA
- $10.2B
- Operating Income
- $9.32B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $8.76B
- Total Debt
- $19.3B
- Net Debt
- $10.6B
- Total Assets
- $127B
- Total Liabilities
- $109B
- Shareholders' Equity
- $17.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $9.45B
- Capital Expenditure
- $1.43B
- Free Cash Flow
- $8.02B
Dividends and risk
Last 12 months- Dividend Yield
- 0.6%
- Dividend / Share
- $1.77
- Beta (5Y)
- 1.38
Every ratio is calculated from the company’s reported figures.